Dr Reddy's

European Commission Approves Dr Reddy’s Biosimilar AVT03 for Osteoporosis and Cancer-Related Bone Conditions

European Commission Approves Dr Reddy’s Biosimilar AVT03 for Osteoporosis and Cancer-Related Bone Conditions

25 Nov 2025

1 min read

India Unveils Updated National Guidelines for Diabetic Retinopathy at National Summit

Policy & Public Health

India Unveils Updated National Guidelines for Diabetic Retinopathy at National Summit

17 Nov 2025

1 min read

EMA Committee Recommends AVT03, a Biosimilar to Prolia and Xgeva, for Marketing Authorisation

EMA Committee Recommends AVT03, a Biosimilar to Prolia and Xgeva, for Marketing Authorisation

23 Sep 2025

1 min read

Read More

Voice Of HealthCare

vohnetwork.com